Single-cell multi-omics analysis of the immune response in COVID-19.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
05 2021
Historique:
received: 15 01 2021
accepted: 23 03 2021
pubmed: 22 4 2021
medline: 25 5 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). We performed single-cell transcriptome, surface proteome and T and B lymphocyte antigen receptor analyses of over 780,000 peripheral blood mononuclear cells from a cross-sectional cohort of 130 patients with varying severities of COVID-19. We identified expansion of nonclassical monocytes expressing complement transcripts (CD16

Identifiants

pubmed: 33879890
doi: 10.1038/s41591-021-01329-2
pii: 10.1038/s41591-021-01329-2
pmc: PMC8121667
doi:

Substances chimiques

Proteome 0
Receptors, Antigen, B-Cell 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

904-916

Subventions

Organisme : Wellcome Trust
ID : 207556/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204721/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K017047/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S005579/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015635/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S035842/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W014556/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P008801/1
Pays : United Kingdom

Investigateurs

Stephen Baker (S)
John R Bradley (JR)
Gordon Dougan (G)
Ian G Goodfellow (IG)
Ravindra K Gupta (RK)
Christoph Hess (C)
Nathalie Kingston (N)
Paul J Lehner (PJ)
Nicholas J Matheson (NJ)
Willem H Owehand (WH)
Caroline Saunders (C)
Kenneth G C Smith (KGC)
Charlotte Summers (C)
James E D Thaventhiran (JED)
Mark Toshner (M)
Michael P Weekes (MP)
Ashlea Bucke (A)
Jo Calder (J)
Laura Canna (L)
Jason Domingo (J)
Anne Elmer (A)
Stewart Fuller (S)
Julie Harris (J)
Sarah Hewitt (S)
Jane Kennet (J)
Sherly Jose (S)
Jenny Kourampa (J)
Anne Meadows (A)
Criona O'Brien (C)
Jane Price (J)
Cherry Publico (C)
Rebecca Rastall (R)
Carla Ribeiro (C)
Jane Rowlands (J)
Valentina Ruffolo (V)
Hugo Tordesillas (H)
Ben Bullman (B)
Benjamin J Dunmore (BJ)
Stuart Fawke (S)
Stefan Gräf (S)
Josh Hodgson (J)
Christopher Huang (C)
Kelvin Hunter (K)
Emma Jones (E)
Ekaterina Legchenko (E)
Cecilia Matara (C)
Jennifer Martin (J)
Ciara O'Donnell (C)
Linda Pointon (L)
Nicole Pond (N)
Joy Shih (J)
Rachel Sutcliffe (R)
Tobias Tilly (T)
Carmen Treacy (C)
Zhen Tong (Z)
Jennifer Wood (J)
Marta Wylot (M)
Ariana Betancourt (A)
Georgie Bower (G)
Aloka De Sa (A)
Madeline Epping (M)
Oisin Huhn (O)
Sarah Jackson (S)
Isobel Jarvis (I)
Jimmy Marsden (J)
Francesca Nice (F)
Georgina Okecha (G)
Ommar Omarjee (O)
Marianne Perera (M)
Nathan Richoz (N)
Rahul Sharma (R)
Lori Turner (L)
Eckart M D D De Bie (EMDD)
Katherine Bunclark (K)
Masa Josipovic (M)
Michael Mackay (M)
Alice Michael (A)
Sabrina Rossi (S)
Mayurun Selvan (M)
Sarah Spencer (S)
Cissy Yong (C)
Ali Ansaripour (A)
Lucy Mwaura (L)
Caroline Patterson (C)
Gary Polwarth (G)
Petra Polgarova (P)
Giovanni di Stefano (GD)
John Allison (J)
Helen Butcher (H)
Daniela Caputo (D)
Debbie Clapham-Riley (D)
Eleanor Dewhurst (E)
Anita Furlong (A)
Barbara Graves (B)
Jennifer Gray (J)
Tasmin Ivers (T)
Mary Kasanicki (M)
Emma Le Gresley (EL)
Rachel Linger (R)
Sarah Meloy (S)
Francesca Muldoon (F)
Nigel Ovington (N)
Sofia Papadia (S)
Isabel Phelan (I)
Hannah Stark (H)
Kathleen E Stirrups (KE)
Paul Townsend (P)
Neil Walker (N)
Jennifer Webster (J)

Références

Bedford, J. et al. COVID-19: towards controlling of a pandemic. Lancet 395, 1015–1018 (2020).
doi: 10.1016/S0140-6736(20)30673-5 pubmed: 32197103 pmcid: 7270596
John Hopkins University. COVID-19 map. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html (2020).
Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).
doi: 10.1016/S0140-6736(20)30211-7 pubmed: 32007143 pmcid: 7135076
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).
pubmed: 32142651 pmcid: 7102627
Diao, B. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 11, 827 (2020).
pubmed: 32425950 pmcid: 7205903
Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).
Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210–1220 (2020).
pubmed: 32788292 pmcid: 7665312
Woodruff, M. C. et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506–1516 (2020).
pubmed: 33028979 pmcid: 7739702
Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620–2629 (2020).
pubmed: 32217835 pmcid: 7190990
Zhang, J.-Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107–1118 (2020).
pubmed: 32788748
Liu, C. et al. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell https://doi.org/10.1016/j.cell.2021.02.018 (2021).
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
pubmed: 32661059 pmcid: 7402632
Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182, 1419–1440 (2020).
pubmed: 32810438 pmcid: 7405822
Mann, E. R. et al. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci. Immunol. 5, eabd6197 (2020).
Bernardes, J. P. et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296–1314 (2020).
pubmed: 33296687 pmcid: 7689306
World Health Organization. Clinical management of COVID-19. https://www.who.int/publications/i/item/clinical-management-of-covid-19 (2021).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693
Severe COVID-19 GWAS Groupet al. Genome-wide association study of severe COVID-19 with respiratory failure. N. Engl. J. Med. 383, 1522–1534 (2020).
Pairo-Castineira, E. et al. Genetic mechanisms of critical illness in COVID-19. Nature https://doi.org/10.1038/s41586-020-03065-y (2020).
Lun, A. T. L., Richard, A. C. & Marioni, J. C. Testing for differential abundance in mass cytometry data. Nat. Methods 14, 707–709 (2017).
pubmed: 28504682 pmcid: 6155493
Jardine, L. et al. Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace. Nat. Commun. 10, 1999 (2019).
pubmed: 31040289 pmcid: 6491485
Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842–844 (2020).
pubmed: 32398875
Evren, E. et al. Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity https://doi.org/10.1016/j.immuni.2020.12.003 (2020).
Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell https://doi.org/10.1016/j.cell.2021.01.053 (2021).
Levi, M., Thachil, J., Iba, T. & Levy, J. H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7, e438–e440 (2020).
pubmed: 32407672 pmcid: 7213964
Hottz, E. D. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood 136, 1330–1341 (2020).
pubmed: 32678428
Velten, L. et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nat. Cell Biol. 19, 271–281 (2017).
pubmed: 28319093 pmcid: 5496982
Mende, N. et al. Quantitative and molecular differences distinguish adult human medullary and extramedullary haematopoietic stem and progenitor cell landscapes. Preprint at BioRxiv https://doi.org/10.1101/2020.01.26.919753 (2020).
Ivanov, S. et al. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J. Virol. 87, 6911–6924 (2013).
pubmed: 23596287 pmcid: 3676141
Desai, N. et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat. Commun. 11, 6319 (2020).
pubmed: 33298930 pmcid: 7725958
Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8
pubmed: 17723218 pmcid: 2034442
Monaco, G. et al. RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 26, 1627–1640 (2019).
pubmed: 30726743 pmcid: 6367568
Adlowitz, D. G. et al. Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response. PLoS ONE 10, e0128269 (2015).
pubmed: 26047509 pmcid: 4457888
Crotty, S. T. T follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132–1148 (2019).
pubmed: 31117010 pmcid: 6532429
Meng, X. et al. Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat. Commun. 9, 251 (2018).
pubmed: 29343683 pmcid: 5772476
Pritchard, N. R. & Smith, K. G. C. B cell inhibitory receptors and autoimmunity. Immunology 108, 263–273 (2003).
pubmed: 12603592 pmcid: 1782894
Doughty, C. A. et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107, 4458–4465 (2006).
pubmed: 16449529 pmcid: 1895797
Boothby, M. & Rickert, R. C. Metabolic regulation of the immune humoral response. Immunity 46, 743–755 (2017).
pubmed: 28514675 pmcid: 5640164
Guan, W.-J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
pubmed: 32109013
Onder, G., Rezza, G. & Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. J. Am. Med. Assoc. 323, 1775–1776 (2020).
Parrot, T. et al. MAIT cell activation and dynamics associated with COVID-19 disease severity. Sci. Immunol. 5, eabe1670 (2020).
Le Bert, N. et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 218, e20202617 (2021).
Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996–1012 (2020).
pubmed: 33010815 pmcid: 7494270
Kaneko, N. et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell 183, 143–157 (2020).
pubmed: 32877699 pmcid: 7437499
Maloy, K. J. et al. CD4
pubmed: 10859340 pmcid: 2193195
Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and T
pubmed: 32998157
Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).
Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315–320 (2020).
pubmed: 32846427 pmcid: 7725931
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886
Heaton, H. et al. Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat. Methods 17, 615–620 (2020).
pubmed: 32366989
McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA-sequencing data using artificial nearest neighbors. Cell Syst. 8, 329–337 (2019).
pubmed: 30954475 pmcid: 6853612
Büttner, M., Miao, Z., Wolf, F. A., Teichmann, S. A. & Theis, F. J. A test metric for assessing single-cell RNA-seq batch correction. Nat. Methods 16, 43–49 (2019).
pubmed: 30573817
Vento-Tormo, R. et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature 563, 347–353 (2018).
pubmed: 30429548
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969
Korotkevich, G., Sukhov, V. & Sergushichev, A. Fast gene-set enrichment analysis. Preprint at BioRxiv https://doi.org/10.1101/060012 (2019).
Haghverdi, L., Lun, A. T. L., Morgan, M. D. & Marioni, J. C. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat. Biotechnol. 36, 421–427 (2018).
pubmed: 29608177 pmcid: 6152897
Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).
McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at https://arxiv.org/abs/1802.03426 (2018).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308
McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288–4297 (2012).
pubmed: 22287627 pmcid: 3378882
Kuleshov, M. V. et al. Enrichr: a comprehensive gene-set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
pubmed: 27141961 pmcid: 4987924
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57, 289–300 (1995).
Ghazanfar, S., Strbenac, D., Ormerod, J. T., Yang, J. Y. H. & Patrick, E. DCARS: differential correlation across ranked samples. Bioinformatics 35, 823–829 (2019).
pubmed: 30102408
Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356–3358 (2015).
pubmed: 26069265 pmcid: 4793929
Lefranc, M.-P. IMGT, the International ImMunoGeneTics Information System. Novartis Found. Symp. 254, 126–142 http://imgt.cines.fr (2008).
Gadala-Maria, D., Yaari, G., Uduman, M. & Kleinstein, S. H. Automated analysis of high-throughput B cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles. Proc. Natl Acad. Sci. USA 112, E862–E870 (2015).
pubmed: 25675496 pmcid: 4345584
Bashford-Rogers, R. J. M. et al. Network properties derived from deep sequencing of human B cell receptor repertoires delineate B cell populations. Genome Res 23, 1874–1884 (2013).
pubmed: 23742949 pmcid: 3814887
Hay, S. B., Ferchen, K., Chetal, K., Grimes, H. L. & Salomonis, N. The human cell atlas bone marrow single-cell interactive web portal. Exp. Hematol. 68, 51–61 (2018).
pubmed: 30243574 pmcid: 6296228

Auteurs

Emily Stephenson (E)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Gary Reynolds (G)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Rachel A Botting (RA)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Fernando J Calero-Nieto (FJ)

Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Michael D Morgan (MD)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Zewen Kelvin Tuong (ZK)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Karsten Bach (K)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Waradon Sungnak (W)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Kaylee B Worlock (KB)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Masahiro Yoshida (M)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Natsuhiko Kumasaka (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Katarzyna Kania (K)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Justin Engelbert (J)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Bayanne Olabi (B)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Jarmila Stremenova Spegarova (JS)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Nicola K Wilson (NK)

Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Nicole Mende (N)

Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Laura Jardine (L)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Louis C S Gardner (LCS)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Issac Goh (I)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Dave Horsfall (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Jim McGrath (J)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Simone Webb (S)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Michael W Mather (MW)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Rik G H Lindeboom (RGH)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Emma Dann (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Ni Huang (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Krzysztof Polanski (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Elena Prigmore (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Florian Gothe (F)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Jonathan Scott (J)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Rebecca P Payne (RP)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Kenneth F Baker (KF)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Aidan T Hanrath (AT)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.

Ina C D Schim van der Loeff (ICD)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Andrew S Barr (AS)

Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.

Amada Sanchez-Gonzalez (A)

Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.

Laura Bergamaschi (L)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Federica Mescia (F)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Josephine L Barnes (JL)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Eliz Kilich (E)

University College London Hospitals NHS Foundation Trust, London, UK.

Angus de Wilton (A)

University College London Hospitals NHS Foundation Trust, London, UK.

Anita Saigal (A)

Royal Free Hospital NHS Foundation Trust, London, UK.

Aarash Saleh (A)

Royal Free Hospital NHS Foundation Trust, London, UK.

Sam M Janes (SM)

UCL Respiratory, Division of Medicine, University College London, London, UK.
University College London Hospitals NHS Foundation Trust, London, UK.

Claire M Smith (CM)

UCL Great Ormond Street Institute of Child Health, London, UK.

Nusayhah Gopee (N)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Department of Dermatology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Caroline Wilson (C)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
The Innovation Lab Integrated COVID Hub North East, Newcastle Upon Tyne, UK.

Paul Coupland (P)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Jonathan M Coxhead (JM)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Vladimir Yu Kiselev (VY)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Stijn van Dongen (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Jaume Bacardit (J)

School of Computing, Newcastle University, Newcastle Upon Tyne, UK.

Hamish W King (HW)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.

Anthony J Rostron (AJ)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Integrated Critical Care Unit, Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.

A John Simpson (AJ)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Sophie Hambleton (S)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Elisa Laurenti (E)

Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Paul A Lyons (PA)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Kerstin B Meyer (KB)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Marko Z Nikolić (MZ)

UCL Respiratory, Division of Medicine, University College London, London, UK.
University College London Hospitals NHS Foundation Trust, London, UK.

Christopher J A Duncan (CJA)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.

Kenneth G C Smith (KGC)

Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. st9@sanger.ac.uk.
Theory of Condensed Matter Group, Cavendish Laboratory/Department of Physics, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk.

Menna R Clatworthy (MR)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK. mrc38@cam.ac.uk.
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. mrc38@cam.ac.uk.
Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. mrc38@cam.ac.uk.
Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Biomedical Campus, Cambridge, UK. mrc38@cam.ac.uk.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK. mrc38@cam.ac.uk.

John C Marioni (JC)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK. marioni@ebi.ac.uk.
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. marioni@ebi.ac.uk.
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. marioni@ebi.ac.uk.

Berthold Göttgens (B)

Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. bg200@cam.ac.uk.

Muzlifah Haniffa (M)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. m.a.haniffa@ncl.ac.uk.
NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.
Department of Dermatology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH